NutriStack
Brimonidine and Cannabis (THC-Dominant), a caution.
THC-dominant cannabis can add to brimonidine-related drowsiness, slowed reactions, dizziness, or blood-pressure symptoms. Brimonidine has documented systemic CNS and cardiovascular adverse effects in susceptible users, while THC acutely impairs psychomotor and driving-related performance. The combination is most concerning with new brimonidine use, high-THC products, older age, or other sedating medicines.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Brimonidine and Cannabis (THC-Dominant)
- Pair type
- Caution
- Evidence (highest tier)
- Emerging
- Source citations
- 3 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Emerging evidence
Caution
What is happening. THC-dominant cannabis can add to brimonidine-related drowsiness, slowed reactions, dizziness, or blood-pressure symptoms. Brimonidine has documented systemic CNS and cardiovascular adverse effects in susceptible users, while THC acutely impairs psychomotor and driving-related performance. The combination is most concerning with new brimonidine use, high-THC products, older age, or other sedating medicines.
Mechanism. Brimonidine's systemic alpha-2 agonism can reduce arousal and sympathetic tone. THC activates CB1 receptors in brain networks controlling attention, tracking, reaction time, and coordination, so the combined effect can be additive functional impairment.
Recommendation. Avoid THC-dominant cannabis when you need to drive or do safety-sensitive tasks after using brimonidine. Use punctal occlusion with eye drops to reduce systemic exposure. If you notice marked sleepiness, dizziness, fainting, or confusion, stop cannabis use and contact your prescriber.
Sources (3)
- Cantor LB. Brimonidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag. 2006;2(4):337-346. PMID 18360646
- Kocis PT, Vrana KE. Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Med Cannabis Cannabinoids. 2020;3(1):61-73. PMID 34676340
- Simmons SM, Caird JK, Sterzer F, Asbridge M. The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta-analysis. Addiction. 2022;117(7):1843-1856. PMID 35083810
Stack Score
How this pair moves the number.
Effect on the composite score
If both Brimonidine and Cannabis (THC-Dominant) are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.